To further investigate the role of complement activation in CRC initiation, we induced CRC by administering AOM and DSS to C3-, C5-, C5ar1-, and C5ar2-deficient mice (Figure S1A) 26. The gene discussed is C3; the disease is colorectal carcinoma.